By browsing this site, you accept the use of Cookies in order to offer you advertising tailored to your interests, to perform traffic statistics and to facilitate the sharing of information on social networks. To find out more about Cookies and to change the Cookies setting, click here

News

Press release 1.20.12 par admin PDF

CFAO announced today the appointment of Jean-Marc Leccia to the post of Chairman and CEO of Eurapharma with effect from 1 July 2012

CFAO announced today the appointment of Jean-Marc Leccia to the post of Chairman and CEO of Eurapharma with effect from 1 July 2012....

CFAO announced today the appointment of Jean-Marc Leccia to the post of Chairman and CEO of Eurapharma with effect from 1 July 2012. Eurapharma is the CFAO’s Group division dedicated to pharmaceutical distribution on the African continent and in the French Overseas Departments and Territories. Jean-Marc Leccia will be replacing Jean-Yves Mazon who will continue to serve as a Member of the Executive Board of the CFAO Group until his term of office expires.

Aged 46, Jean-Marc Leccia is a graduate of EPSCI and began his career with Laboratoires Baxter, responsible for exports in Africa. He went on to join Eurapharma in 1991 where he was responsible for promotional activities and then, in 2000, set up the Pre-Wholesale business Epdis France. Since 2005 Jean-Marc Leccia has also been in charge of developing and supervising the growth of Eurapharma business activities in English-speaking and Portuguese-speaking Africa as well as in Algeria.


Go to top